Media ReleasesImugene Limited

View All Imugene Limited News


Imugene appoints Professor Yuman Fong, MD, of City of Hope to Chair Oncolytic Virotherapy Scientific Advisory Board

Sydney, Australia, 17 October 2019: Imugene Limited (ASX:IMU) a clinical stage immuno-oncology company today announced the appointment of Professor Yuman Fong, MD, Chair of the Department of Surgery at City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases based near Los Angeles, to head up its newly formed oncolytic virotherapy (OV) Scientific Advisory Board (SAB).

For further information please download the attached PDF:
Download this document